GCP
RGLS

GSA Capital Partners’s Regulus Therapeutics RGLS Stock Holding History

GSA Capital Partners’s Portfolio RGLS Stock Details RGLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-6,471
Closed -$45K – 1737
2021
Q3 		$45K Sell
6,471
-14,156
-69% -$104K ﹤0.01% 1349
2021
Q2 		$168K Buy
+20,627
New +$230K 0.02% 1210
2017
Q4 		– Sell
-1,698
Closed -$255K – 1777
2017
Q3 		$255K Buy
1,698
+525
+45% +$66K 0.02% 1333
2017
Q2 		$139K Buy
+1,173
New +$196K 0.01% 1559
2016
Q2 		– Sell
-120
Closed -$100K – 1877
2016
Q1 		$100K Buy
+120
New +$95.5K 0.01% 1583
2014
Q1 		– Sell
-106
Closed -$94K – 1763
2013
Q4 		$94K Buy
+106
New +$91.3K 0.01% 1570

Other funds holding RGLS

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Asymmetry Capital Management San Francisco, California $188M AUM 44.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return